New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong
· Delayed Price · Currency is HKD 0.200
0.00 (0.00%)
At close: Apr 29, 2026
HKG:6108 Revenue
In the year 2025, New Ray Medicine International Holding had annual revenue of 130.37M HKD with 38.78% growth. New Ray Medicine International Holding had revenue of 85.67M in the half year ending December 31, 2025, with 347.66% growth.
Revenue
130.37M
Revenue Growth
+38.78%
P/S Ratio
0.31
Revenue / Employee
4.21M
Employees
31
Market Cap
40.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.37M | 36.43M | 38.78% |
| Dec 31, 2024 | 93.95M | 43.79M | 87.31% |
| Dec 31, 2023 | 50.15M | -39.62M | -44.13% |
| Dec 31, 2022 | 89.77M | -245.61M | -73.23% |
| Dec 31, 2021 | 335.38M | 202.17M | 151.76% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Universal Health International Group Holding | 597.78M |
| Pa Shun International Holdings | 96.60M |
| China Healthwise Holdings | 99.56M |
| Tycoon Group Holdings | 1.10B |
| Kingworld Medicines Group | 1.02B |
| Fangzhou | 3.92B |
| Shanghai Pioneer Holding | 1.43B |
| YSB Inc. | 23.34B |